vimarsana.com
  1. Home
  2. Live Updates
  3. Edigene Ag - Breaking News

Latest Breaking News On - Edigene ag - Page 1 : vimarsana.com

Medigene Presents Enhanced Tumor Cell Killing Effects upon

Planegg/Martinsried, 22 June 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and.

United kingdomCity ofPamela keckDolores schendelPlanegg martinsriedBb switch receptor technologyPrime standardImmuno oncology summit europe juneReceptor technology addedChief scientific officerProgrammed death ligandFrankfurt exchange mdg1Edigene agTcr based therapies

Medigene to present first pre-clinical data for MDG1015

Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the.

United statesKathrin mutzeDoloresj schendelBarbara loeschPamela keckStefanie tippmerPetra prinzKathrin davariMaja buerdekGiulia longinottiAndrea coluccioHongsheng sciencesPrime standardAmerican associationCancer research virtual annual meetingAdoptive cell

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.